Karuna Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KRTX research report →
Companywww.karunatx.com
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis.
- CEO
- William Meury
- IPO
- 2019
- Employees
- 339
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $12.60B
- P/E
- -28.11
- P/S
- 19264.95
- P/B
- 9.72
- EV/EBITDA
- -25.21
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -160.09%
- Op Margin
- -75653.98%
- Net Margin
- -66311.93%
- ROE
- -36.44%
- ROIC
- -38.93%
Growth & Income
- Revenue
- $654.00K · -93.85%
- Net Income
- $-433,680,000 · -56.94%
- EPS
- $-11.73 · -34.21%
- Op Income
- $-494,777,000
- FCF YoY
- -69.81%
Performance & Tape
- 52W High
- $329.99
- 52W Low
- $158.38
- 50D MA
- $317.38
- 200D MA
- $228.31
- Beta
- 1.15
- Avg Volume
- 971.83K
Get TickerSpark's AI analysis on KRTX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 24 | Wheadon David E. | sell | 25,000 |
| Mar 18, 24 | Wheadon David E. | sell | 8,500 |
| Mar 18, 24 | Wheadon David E. | sell | 990 |
| Mar 18, 24 | Wheadon David E. | sell | 5,000 |
| Mar 18, 24 | Wheadon David E. | sell | 1,904 |
| Mar 18, 24 | Torres Denice | sell | 990 |
| Mar 18, 24 | Torres Denice | sell | 5,000 |
| Mar 18, 24 | Torres Denice | sell | 1,904 |
| Mar 18, 24 | Torres Denice | sell | 8,500 |
| Mar 18, 24 | Torres Denice | sell | 25,000 |
Our KRTX Coverage
We haven't published any research on KRTX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KRTX Report →